Companies: 10,795·Total market cap: $144.5T
Allarity Therapeutics, Inc.

Allarity Therapeutics, Inc.

ALLRNASDAQHealthcare● Active
$1.62
+$0.04(+2.53%)
Market Cap$25775373
P/E Ratio—
52W High$2.35
52W Low$0.769
Overview

Allarity Therapeutics, Inc. (ALLR) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · ALLR · as of Mar 30, 2026

Latest filing snapshot

8
+1+14.29%vs prior year

Allarity Therapeutics, Inc. (ALLR) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global
Total Employees
8
Change (1Y)
+1
Growth % (1Y)
+14.29%
Revenue / Employee
$40.0K
Net Income / Employee
$-1.40M
Market Cap
$25M

ALLR Employee Count

2021 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-03-308+1+14.29%
2025-03-317+1+16.67%
2024-03-086-3-33.33%
2023-03-139-4-30.77%
2022-05-1713——

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
CASI Pharmaceuticals, Inc.
CASI
CASI Pharmaceuticals, Inc.
233#2
Curis, Inc.
CRIS
Curis, Inc.
34#3
Clearside Biomedical, Inc.
CLSD
Clearside Biomedical, Inc.
32#4
BriaCell Therapeutics Corp.
BCTX
BriaCell Therapeutics Corp.
16#5
Cingulate Inc.
CING
Cingulate Inc.
13#6
Allarity Therapeutics, Inc.
ALLR
Allarity Therapeutics, Inc.YOU
8#7
Entero Therapeutics, Inc.
ENTO
Entero Therapeutics, Inc.
2
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · ALLR peer comparison

About ALLR employees

ALLR Employees · Headcount

Allarity Therapeutics, Inc. (ALLR) employee data is sourced from the annual SEC 10-K filing. As of 2025, Allarity Therapeutics, Inc. had 8 full-time employees globally. Full-time employees only. Global consolidated headcount.

Allarity Therapeutics, Inc. employs 8 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $40,000, reflecting the company's operational efficiency.

Allarity Therapeutics, Inc.'s workforce increased by 1 (14.29%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Allarity Therapeutics, Inc.'s revenue per employee of $40,000 positions it among the notable performers in the Biotechnology sector for operational efficiency.

RevenueFinancial statementsNet incomeSEC filingsPrice historyForecast & ratingsOwnershipEarnings

Frequently Asked Questions

ALLR Employees · 5 questions

As of the latest SEC 10-K filing (2025), Allarity Therapeutics, Inc. had 8 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Allarity Therapeutics, Inc. employee counthow many employees does Allarity Therapeutics, Inc. haveALLR total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-30